Abstract
Little is known about severe acute respiratory syndrome coronavirus 2 “vaccine-breakthrough” infections (VBIs). Here we characterize 24 VBIs in predominantly young healthy persons. While none required hospitalization, a proportion endorsed severe symptoms and shed live virus as high as 4.13 × 103 plaque-forming units/mL. Infecting genotypes included both variant-of-concern (VOC) and non-VOC strains.
Keywords: SARS-CoV-2; live virus; patient-reported outcomes; symptoms; vaccine breakthrough.
All Keywords
【저자키워드】 SARS-CoV-2, Symptoms, Patient-reported outcomes, Live virus, Vaccine breakthrough, 【초록키워드】 Vaccine, coronavirus, Hospitalization, VoC, Infection, severe acute respiratory syndrome Coronavirus, Genotype, Strains, Live virus, acute respiratory syndrome, acute respiratory syndrome coronavirus, severe symptoms, while, proportion, healthy, required, severe symptom, 【제목키워드】 coronavirus 2, mRNA, shedding, respiratory, Diversity, Significant,
【저자키워드】 SARS-CoV-2, Symptoms, Patient-reported outcomes, Live virus, Vaccine breakthrough, 【초록키워드】 Vaccine, coronavirus, Hospitalization, VoC, Infection, severe acute respiratory syndrome Coronavirus, Genotype, Strains, Live virus, acute respiratory syndrome, acute respiratory syndrome coronavirus, severe symptoms, while, proportion, healthy, required, severe symptom, 【제목키워드】 coronavirus 2, mRNA, shedding, respiratory, Diversity, Significant,
{{{ 추상적인 }}}
중증 급성 호흡기 증후군 코로나바이러스 2 "백신 돌파" 감염(VBI)에 대해서는 알려진 바가 거의 없습니다. 여기에서 우리는 주로 젊고 건강한 사람들에서 24개의 VBI를 특성화합니다. 입원이 필요한 환자는 없었지만 일부 환자는 심각한 증상을 보였고 최대 4.13 × 103 플라크 형성 단위/mL의 살아있는 바이러스를 배출했습니다. 감염 유전자형에는 관심 변형(VOC) 및 비 VOC 균주가 모두 포함되었습니다.
{{ 키워드: }} SARS-CoV-2; 살아있는 바이러스; 환자 보고 결과; 증상; 백신 돌파구.